P
Prostatype Genomics AB
STO:PROGEN
Prostatype Genomics AB
STO:PROGEN
Price:
0.158
SEK
-7.87%
Market Closed
Market Cap:
kr84.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Prostatype Genomics AB
STO:PROGEN
|
SE |
|
Lake Winn Resources Corp
F:EE1
|
CA |
|
C
|
Cts Eventim AG & Co KgaA
DUS:EVD
|
DE |
|
China Everbright Water Ltd
OTC:BOTRF
|
CN |
|
Conico Ltd
F:BDD
|
AU |
|
S
|
SBI Insurance Group Co Ltd
F:EEW
|
JP |
|
Santen Pharmaceutical Co Ltd
OTC:SNPHF
|
JP |
|
V
|
Voltabox AG
SWB:VBX
|
DE |
|
CellaVision AB
F:C26
|
SE |
|
China High Speed Transmission Equipment Group Co Ltd
OTC:CHSTY
|
HK |
|
ASBISc Enterprises PLC
F:J1L
|
CY |
|
A
|
Avalon Globocare Corp
F:2XJ0
|
US |
|
H
|
Helix Biopharma Corp
OTC:HBPCF
|
CA |
|
Preveceutical Medical Inc
F:18H
|
CA |
|
Salmon Evolution ASA
F:60E
|
NO |
|
C
|
Cyren Ltd
F:TOU
|
IL |
|
H
|
Hongkong Chinese Ltd
F:HKC
|
HK |
|
S
|
Shougang Century Holdings Ltd
F:CW7
|
HK |
|
Cinda International Holdings Ltd
F:HNT
|
HK |
|
H
|
Honghua Group Ltd
XMUN:4HB
|
CN |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PROGEN's stock price target?
Not Available
PROGEN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Prostatype Genomics AB?
Projected CAGR
2 025%
2 025%
Over the last 9 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 1 year is 2 025%.
